COST-EFFECTIVENESS ANALYSIS OF TREATMENT IN GASTROESOPHAGEAL REFLUX DISEASE INPATIENT PATIENTS IN BANDUNG, INDONESIA

RIANI TANJUNG; YULIA WARDATI; YUYUN YULIANINGSIH; IDA ERNA WIDYAWATI; RESMI MUSTARICHIE; NYI MEKAR SAPTARINI

doi:10.22159/ijap.2023.v15s2.26

Authors

RIANI TANJUNG Department of Accounting, Universitas Logistik dan Bisnis Internasional, Bandung-40151 West Java, Indonesia
YULIA WARDATI Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Al Ghifari University, Bandung-40293, West Java, Indonesia
YUYUN YULIANINGSIH Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Al Ghifari University, Bandung-40293, West Java, Indonesia
IDA ERNA WIDYAWATI Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Al Ghifari University, Bandung-40293, West Java, Indonesia
RESMI MUSTARICHIE Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran-45363, West Java, Indonesia
NYI MEKAR SAPTARINI Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran-45363, West Java, Indonesia

DOI:

https://doi.org/10.22159/ijap.2023.v15s2.26

Keywords:

BPJS, GERD, LOS, Omeprazole, Pantoprazole

Abstract

Objective: This study aimed to analyze the cost-effectiveness of the GERD treatment management strategy for class II inpatient patients at a police hospital in Bandung, Indonesia.

Methods: This study was retrospective, using medical record data collection techniques for 103 patients of the Social Security Administrator for Health (Badan Penyelenggara Jaminan Sosial, BPJS), from January 2017 to July 2019. The pharmacoeconomic method was Cost-Effectiveness Analysis. The medicines being compared were omeprazole injection and pantoprazole injection. The outcome parameter was the length of stay (LOS). The perspective was a hospital with a direct cost component. This study uses a 5% discounting rate due to differences in years.

Results: The results showed that the patient majority was female (76%) and the largest age group was>40 y (53%). There was a significant difference in LOS and total cost between omeprazole and pantoprazole (p-value<0.050) using the Mann-Whitney test. The cost-effectiveness ratio showed that omeprazole has a higher value than pantoprazole.

Conclusion: Therapy using pantoprazole was more cost-effective than omeprazole.

Downloads

Download data is not yet available.

References

Dore MP, Graham DY. Ulcers and gastritis. Endoscopy. 2004;36(1):42-7. doi: 10.1055/s-2004-814115.

Hershcovici T, Fass R. Gastroesophageal reflux disease. In: Hawkey CJ, Bosch J, Richter JE, Garcia Tsao G, Chan FKL, editors. Textbook of clinical gastroenterology and hepatology. 2nd ed. John Wiley & Sons; 2012. p. 175-93. doi: 10.1002/9781118321386.ch27.

Puspita FC, Putri LA, Rahardja C, Utari AP, Syam AF. Prevalence of gastroesophageal reflux disease and its risk factors in rural area. InaJGHE. 2017;18(1):9-14. doi: 10.24871/18120179-14.

Fock KM, Talley N, Hunt R, Fass R, Nandurkar S, Lam S. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004;19(4):357-67. doi: 10.1111/j.1440-1746.2004.03419.x.

Syam AF, Aulia C, Renaldi K, Simadibrata M, Abdullah M, Tedjasaputra TR. Revisi konsensus nasional penatalaksanaan penyakit refluks gastroesophageal (gastroesophageal reflux disease/GERD) di Indonesia. Jakarta: Perkumpulan Gastroenterologi Indonesia; 2013. p. 2-4.

Kemkes. Kementrian kesehatan republik Indonesia. Jakarta: Kementrian Kesehatan Republik Indonesia. Pedoman Penerapan Kajian Farmakoekonomi; 2013. p. 1-96. Available from: https://farmalkes.go.id/2014/02/pedoman-penerapan-kajian-farmakoekonomi.

Tanjung R, Wardati Y, Azizah DN, Pratiwi B, Mustarichie R, Saptarini NM. Cost-effectiveness analysis of gastritis therapy in an Air Force hospital in Bandung, Indonesia. Int J App Pharm. 2022;14Special Issue 4:67-72. doi: 10.22159/ijap.2022.v14s4.PP06.

Sukengtyas DAT, Andayani TM, Budiarti LE. Kajian efektivitas dan biaya terapi penggunaan omeprazol dan pantoprazol sebagai profilaksis stress related mucosal disese di ICU. J Manaj Pelayanan Farm. 2017;7(2):57-64.

Fisichella PM, Schlottmann F, Patti MG. Evaluation of gastroesophageal reflux disease. Updates Surg. 2018;70(3):309-13. doi: 10.1007/s13304-018-0563-z.

Schulze K, Christensen J. Lower sphincter of the opossum esophagus in pseudopregnancy. Gastroenterology. 1977;73(5):1082-5. doi: 10.1016/S0016-5085(19)31862-1.

Patti MG. Gastroesophageal reflux disease. Medscape. Available from: https://emedicine.com/article/176595-overview?form=fpf. [Last accessed on 21 Nov 2023]

Pitchumoni CS, Dharmarajan TS. Geriatric gastroenterology. New York: Springer; 2012. p. 1-711.

Johansson KE, Ask P, Boeryd B, Fransson SG, Tibbling L. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1986;21(7):837-47. doi: 10.3109/00365528609011128.

Bell NJ, Hunt RH. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut. 1992;33(1):118-24. doi: 10.1136/gut.33.1.118.

Johnsson F, Weywadt L, Solhaug JH, Hernqvist H, Bengtsson L. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1998;33(1):15-20. doi: 10.1080/00365529850166149.

Fass R, Ofman JJ, Sampliner RE, Camargo L, Wendel C, Fennerty MB. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther. 2000;14(4):389-96. doi: 10.1046/j.1365-2036.2000.00733.x.

Kementrian kesehatan republik Indonesia. Peraturan Mentri Kesehatan No 28 tentang pedoman pelaksanaan program Jaminan Kesehatan Nasional; 2014. Available from: https://peraturan.bpk.go.id/home/details/117565/permenkes-no-28-tahun-2014. [Last accessed on 21 Nov 2023]